InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Gardner Jason, Autre. Insider active across 1 company, notably Magenta Therapeutics, Inc.. Cumulatively, 4 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €82k. Activity tracked since 14 September 2021. The latest transaction was filed on 30 November 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Gardner Jason
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
3,000 shares@ US$0.941.6% of flowCommon StockSEC:0000899243-22-037431:0
3,000 shares@ US$0.993.2% of flowCommon StockSEC:0000899243-22-021184:0
14,340 shares@ US$6.7393.7% of flowCommon StockSEC:0000899243-21-036599:0
50,000 shares0Common StockSEC:0000899243-21-036335:0
4 of 4 declarations
About Gardner Jason
Jason Gardner is a senior executive at Magenta Therapeutics, Inc. He holds a leadership position in international optimization and strategic initiatives. His role is essential in guiding the company in its innovation and transformation efforts.
